Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhinitis | 4 | 2024 | 41 | 2.270 |
Why?
|
| Sinusitis | 4 | 2024 | 116 | 2.150 |
Why?
|
| Nasal Polyps | 2 | 2021 | 28 | 0.870 |
Why?
|
| Biological Therapy | 1 | 2021 | 26 | 0.690 |
Why?
|
| Chronic Disease | 3 | 2024 | 1233 | 0.410 |
Why?
|
| Asthma | 1 | 2021 | 927 | 0.370 |
Why?
|
| Endoscopy | 2 | 2024 | 282 | 0.270 |
Why?
|
| Pott Puffy Tumor | 1 | 2025 | 4 | 0.240 |
Why?
|
| Odontoid Process | 1 | 2024 | 10 | 0.220 |
Why?
|
| Chordoma | 1 | 2024 | 18 | 0.220 |
Why?
|
| Cranial Nerves | 1 | 2024 | 21 | 0.220 |
Why?
|
| Pons | 1 | 2024 | 34 | 0.220 |
Why?
|
| Nasal Septum | 1 | 2024 | 22 | 0.210 |
Why?
|
| Cervical Vertebrae | 1 | 2024 | 113 | 0.210 |
Why?
|
| Adenoidectomy | 1 | 2024 | 84 | 0.200 |
Why?
|
| Catheterization | 1 | 2024 | 233 | 0.200 |
Why?
|
| Craniopharyngioma | 1 | 2023 | 34 | 0.190 |
Why?
|
| Pituitary Neoplasms | 1 | 2023 | 78 | 0.180 |
Why?
|
| Neurosurgical Procedures | 1 | 2024 | 316 | 0.180 |
Why?
|
| Proton Therapy | 1 | 2023 | 156 | 0.170 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2023 | 342 | 0.160 |
Why?
|
| Heart Arrest | 1 | 2023 | 379 | 0.150 |
Why?
|
| Quality of Life | 3 | 2024 | 2107 | 0.130 |
Why?
|
| Comorbidity | 1 | 2021 | 1590 | 0.120 |
Why?
|
| Treatment Outcome | 4 | 2024 | 12936 | 0.110 |
Why?
|
| Child | 6 | 2024 | 26239 | 0.110 |
Why?
|
| Thyroglobulin | 1 | 2014 | 7 | 0.110 |
Why?
|
| Iodine Radioisotopes | 1 | 2014 | 74 | 0.110 |
Why?
|
| Delphi Technique | 2 | 2025 | 262 | 0.100 |
Why?
|
| Thyroidectomy | 1 | 2014 | 101 | 0.100 |
Why?
|
| Humans | 11 | 2025 | 131504 | 0.100 |
Why?
|
| Anesthesia, Intravenous | 1 | 2012 | 7 | 0.100 |
Why?
|
| Anesthesia, Inhalation | 1 | 2012 | 12 | 0.100 |
Why?
|
| Paranasal Sinuses | 1 | 2012 | 18 | 0.100 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 248 | 0.090 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 1322 | 0.080 |
Why?
|
| Aquaporin 4 | 1 | 2009 | 15 | 0.080 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2009 | 21 | 0.080 |
Why?
|
| Intestinal Diseases | 1 | 2009 | 68 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2025 | 3911 | 0.070 |
Why?
|
| Edema | 1 | 2009 | 139 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2024 | 17648 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 764 | 0.050 |
Why?
|
| Drainage | 1 | 2025 | 252 | 0.050 |
Why?
|
| Rhinoplasty | 1 | 2024 | 49 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2023 | 155 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8589 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2023 | 215 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 794 | 0.040 |
Why?
|
| Adolescent | 3 | 2024 | 20917 | 0.040 |
Why?
|
| Male | 6 | 2024 | 65158 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2024 | 15047 | 0.040 |
Why?
|
| Infant | 2 | 2024 | 13300 | 0.040 |
Why?
|
| Female | 5 | 2024 | 71087 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 1939 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2014 | 119 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 90 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 2566 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2014 | 330 | 0.020 |
Why?
|
| Methyl Ethers | 1 | 2012 | 23 | 0.020 |
Why?
|
| Anesthetics, Intravenous | 1 | 2012 | 47 | 0.020 |
Why?
|
| Propofol | 1 | 2012 | 48 | 0.020 |
Why?
|
| Anesthetics, Inhalation | 1 | 2012 | 44 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2024 | 3113 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 168 | 0.020 |
Why?
|
| Piperidines | 1 | 2012 | 232 | 0.020 |
Why?
|
| Ascitic Fluid | 1 | 2009 | 29 | 0.020 |
Why?
|
| Urine | 1 | 2009 | 92 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 333 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 421 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1634 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11794 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1450 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2985 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 832 | 0.020 |
Why?
|
| Resuscitation | 1 | 2009 | 269 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1148 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1610 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1617 | 0.010 |
Why?
|
| Aged | 2 | 2014 | 21238 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 5277 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 1390 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 3454 | 0.010 |
Why?
|
| Middle Aged | 2 | 2014 | 28839 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6916 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 31666 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 6485 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 10092 | 0.010 |
Why?
|
| Animals | 1 | 2009 | 34341 | 0.000 |
Why?
|